TEHRAN UNIVERSITY OF MEDICAL SCIENCES
🇮🇷Iran
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1934-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.tums.ac.ir
Evaluation of Pain Reduction After Hemorrhoidectomy With Use of Diltiazim Ointment 2%
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2009-05-05
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 1
- Registration Number
- NCT00893100
- Locations
- 🇮🇷
Sina General Hospital, Tehran, Iran, Islamic Republic of
Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide
- First Posted Date
- 2009-02-24
- Last Posted Date
- 2009-02-24
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 10
- Registration Number
- NCT00850304
- Locations
- 🇮🇷
Hematology-Oncology and SCT Research Center, Tehran, Iran, Islamic Republic of
Reduction of Secondhand Smoke Exposure in Healthy Infants
Not Applicable
Completed
- Conditions
- Secondhand Smoke Exposure
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2009-10-06
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 130
- Registration Number
- NCT00821639
- Locations
- 🇮🇷
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DM
Phase 4
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Dietary Supplement: EPA, Vitamin E
- First Posted Date
- 2009-01-06
- Last Posted Date
- 2009-11-18
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 129
- Registration Number
- NCT00817622
- Locations
- 🇮🇷
Tehran University Of Medical Sciences, Tehran, Iran, Islamic Republic of
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
Phase 3
Completed
- Conditions
- Radiocontrast-Induced NephropathyChronic Kidney DiseaseDiabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-12-16
- Last Posted Date
- 2008-12-16
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 90
- Registration Number
- NCT00808795
- Locations
- 🇮🇷
Tehran Heart center, Tehran, Iran, Islamic Republic of
131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma
Phase 1
- Conditions
- Neuroblastoma
- Interventions
- Drug: 131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation
- First Posted Date
- 2008-11-25
- Last Posted Date
- 2012-06-04
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 10
- Registration Number
- NCT00798148
- Locations
- 🇮🇷
Hematology-Oncology & SCT Research Center, Tehran, Iran, Islamic Republic of
🇮🇷Research Institute for Nuclear Medicine, Tehran, Iran, Islamic Republic of
The Effect of Packing in Post Operative Management of FESS
Phase 4
Completed
- Conditions
- EpistaxisNasal ObstructionPain
- Interventions
- Procedure: packing
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2012-06-05
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 66
- Registration Number
- NCT00793117
- Locations
- 🇮🇷
Imam Khomaimee hospital, Tehran, Iran, Islamic Republic of
Karydakis Procedure Versus Excision With Healing by Secondary Intention (EHSI) in Sacrococcygeal Pilonidal Sinus
Phase 4
Completed
- Conditions
- Pilonidal CystPilonidal Sinus
- Interventions
- Procedure: karydakis flapProcedure: laying open
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2014-12-16
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 321
- Registration Number
- NCT00716937
- Locations
- 🇮🇷
Tehran University of medical Sciences, Deputy of Research, Tehran, Iran, Islamic Republic of
Psychological Symptoms in Patients With Behcet's Disease by SCL90-R
Completed
- Conditions
- Behcet's Syndrome
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 400
- Registration Number
- NCT00699985
- Locations
- 🇮🇷
Rheumatology Research Center, Shariati Hospital, Tehran, Iran, Islamic Republic of
Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2008-06-18
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 169
- Registration Number
- NCT00700297
- Locations
- 🇮🇷
Rheumatology research Center, Tehran UMS, Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath